CryoLife, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9.4M | 1,102 | 86.1% |
| Consulting Fee | $600,720 | 198 | 5.5% |
| Travel and Lodging | $392,832 | 851 | 3.6% |
| Food and Beverage | $272,470 | 4,579 | 2.5% |
| Honoraria | $248,055 | 91 | 2.3% |
| Royalty or License | $564.16 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot Polysaccharide Hemostatic System | $3.5M | 0 | 221 |
| Clinical Trial of the On-X Valve using low dose Anticoagulation | $3.3M | 0 | 31 |
| Clinical Trial of the ON-X Valve using low dose Anticoagulation | $425,658 | 0 | 191 |
| Post-market, prospective evaluation of PHOTO-oxidized decellularized bovine pericardium used as a patch in Vascular repair and reconstruction surgery | $380,524 | 0 | 64 |
| Clinical trial of the On-X Valve using low dose anticoagulation | $273,157 | 0 | 79 |
| On-X aortic prosthetic heart valve: Low dose warfarin post approval clinical registry study | $251,969 | 0 | 88 |
| Postmarket, prospective evaluation of human placental membrane tissue used as a wound cover for chronic foot ulcers in patients with diabetes | $242,826 | 0 | 17 |
| ON-X Aortic Prosthetic Heart Valve: Low dose Warfarin Post Approval | $205,155 | 0 | 62 |
| Clinical Trial of the ON-X Valve using low dose Anticoagulation (PROACT) | $137,896 | 0 | 49 |
| Clinical Trial of the On-X Valve using low Dose Anticoagulation | $113,312 | 0 | 46 |
| ON-X Aortic Prosthetic Heart Valve: Low dose Warfarin Post Approval Clinical Registry Study (PAS) | $103,265 | 0 | 29 |
| Prospective Randomized On-X valve Anticoagulation Clinical Trial (PROACT) | $84,500 | 0 | 31 |
| A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban | $83,452 | 0 | 18 |
| On-X aortic prosthetic heart valve: Low dose warfarin post approval clinical registry | $65,009 | 0 | 31 |
| ON-X Prosthetic Heart Valve-Anatomic Suture Ring Postmarket Registry | $61,048 | 0 | 26 |
| ON-X Prosthetic Heart Valve-size 17mm Aortic and 23mm Mitral | $39,942 | 0 | 18 |
| CryoValve Aortic Valve Allograft Retrospective Multi-Center Study | $37,600 | 0 | 1 |
| A Multi-Center Single Arm One Year Prospective Follow-Up of Patients Treated with the CryoLife CardioGenesis Holmium:YAG Laser System for Transmyocardial Revascularization: The TMR 365 Study (TMR1501.000-M) | $35,940 | 0 | 5 |
| On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study | $31,900 | 0 | 26 |
| A Multi-Center Single Arm One Year Prospective Follow-Up of Patients Treated with the Cryolife CardioGenesis Holmlum:YAG Laser System for TransmyocardialRevascularization | $28,878 | 0 | 2 |
| On-X Prosthetic Heart Valve- Sizes 17mm Aortic and 23mm Mitral | $21,555 | 0 | 2 |
| Prospective Randomized On-X Valve Anticoagulation Trial (PROACT) | $20,617 | 0 | 16 |
| On-X Aortic Prosthetic Heart Valve Registry | $18,645 | 0 | 12 |
| A Multi-Center Single Arm Observational Registry of the Cardiogenesis Holmium: YAG laser System Transmyocardial Revascularization for Angina Reduction | $18,250 | 0 | 7 |
| Postmarket, prospective evaluation of human placental membrane tissue used as an adjunct for foot and ankle tendon surgery in patients with chronic tendinopathy | $11,000 | 0 | 5 |
| Prospective Randomized On-X valve Anticoagulation Clinical Trial | $6,346 | 0 | 12 |
| On-X Prosthetic Heart Valve- Anatomic Suture Ring Postmarket Registry | $4,000 | 0 | 1 |
| Prospective Randomized On-X valve Anticoagulation Clinical | $2,000 | 0 | 7 |
| Prospective, Multicenter, Primary Below the Knee Bypass Evaluation with CryoVein Cryopreserved Saphenous Vein Allograft in Patients with Critical Limb Ischemia | $725.00 | 0 | 1 |
| ON-X Aortic Prosthetic Heart Valve: Low dose Warfarin Post Approval Clinical Registry Study | $550.00 | 0 | 2 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Dr. Sidney Levitsky, M.d, M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Boston, MA | $164,289 | $0 |
| Richard Engelman, Md, MD | Surgery | Springfield, MA | $60,050 | $0 |
| Dr. Marc Gerdisch, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Indianapolis, IN | $56,323 | $0 |
| Dr. Glenn Barnhart, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Seattle, WA | $52,767 | $0 |
| Vincent Gaudiani, Md, MD | Transplant Surgery | Palo Alto, CA | $45,955 | $0 |
| Dr. Douglas Pacaccio, Dpm, DPM | Podiatrist | Rockford, IL | $34,548 | $0 |
| Dr. Mohanakrishnan Sathyamoorthy, M.d, M.D | Cardiovascular Disease | Fort Worth, TX | $33,245 | $0 |
| John Fehrenbacher, M.d, M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Indianapolis, IN | $30,861 | $0 |
| V Reddy, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Nashville, TN | $19,889 | $0 |
| Eric Feins, M.d, M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Boston, MA | $17,174 | $0 |
| Dr. Keith Allen, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Kansas City, KS | $15,974 | $0 |
| Elizabeth Holper, M.d, M.D | Cardiovascular Disease | Fort Worth, TX | $14,880 | $0 |
| Dr. Lynn Mathia, D.o, D.O | Surgery | Clinton Twp, MI | $14,506 | $0 |
| Pei Tsau, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Palo Alto, CA | $14,346 | $0 |
| Dr. Sailesh Shah, M.d, M.D | Cardiovascular Disease | Sacramento, CA | $14,263 | $0 |
| A Gillinov, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Cleveland, OH | $12,561 | $0 |
| Eric Roselli, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Cleveland, OH | $11,731 | $0 |
| Sameh Said, Mbbch, Md, MBBCH, MD | Surgery | Valhalla, NY | $10,982 | $0 |
| S. Christopher Malaisrie, M.d, M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Chicago, IL | $10,331 | $0 |
| Dr. Pedro Del Nido, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Boston, MA | $9,390 | $0 |
| Yu Ping Wang, Md, MD | Cardiovascular Disease | Stanford, CA | $9,351 | $0 |
| Maurice Enriquez Sarano, M.d, M.D | Cardiovascular Disease | Rochester, MN | $9,298 | $0 |
| Emile Bacha, Md, MD | Surgery | New York, NY | $9,140 | $0 |
| Dr. Per Wierup, Md Phd, MD PHD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Cleveland, OH | $9,058 | $0 |
| Brian Olshansky, Md, MD | Internal Medicine | Iowa City, IA | $8,583 | $0 |
About CryoLife, Inc.
CryoLife, Inc. has made $10.9M in payments to 1,724 healthcare providers, recorded across 6,822 transactions in the CMS Open Payments database. In 2020, the company paid $1.5M. The top product by payment volume is On-X ($6.0M).
Payments were distributed across 42 medical specialties. The top specialty by payment amount is Thoracic Surgery (Cardiothoracic Vascular Surgery) ($894,279 to 781 doctors).
Payment categories include: Food & Beverage ($272,470), Consulting ($600,720), Research ($9.4M), Travel & Lodging ($392,832), Royalties ($564.16).
CryoLife, Inc. is associated with 7 products in the CMS Open Payments database, including On-X, PerClot, and PhotoFix.